Isao Teshirogi, Shionogi CEO (Kiyoshi Ota/Bloomberg via Getty Images)

Covid-19 roundup: Sh­iono­gi vac­cine proves ef­fec­tive — re­port; Eli Lil­ly, In­cyte's JAK re­duces death, study finds

As the fam­i­ly of pro­tein-based Covid-19 vac­cines con­tin­ues to push for­ward, one com­pa­ny has re­port­ed­ly found its shot to be safe and ef­fec­tive.

Japan’s Sh­iono­gi …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.